Marc Van Regenmortel

2.1k total citations · 1 hit paper
9 papers, 1.6k citations indexed

About

Marc Van Regenmortel is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Marc Van Regenmortel has authored 9 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Immunology. Recurrent topics in Marc Van Regenmortel's work include Monoclonal and Polyclonal Antibodies Research (4 papers), vaccines and immunoinformatics approaches (2 papers) and Glycosylation and Glycoproteins Research (2 papers). Marc Van Regenmortel is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), vaccines and immunoinformatics approaches (2 papers) and Glycosylation and Glycoproteins Research (2 papers). Marc Van Regenmortel collaborates with scholars based in France, United States and Argentina. Marc Van Regenmortel's co-authors include Étienne Weiss, Patrick Chames, Daniel Baty, Jean‐Luc Pellequer, Shu‐wen W. Chen, Adrian G. Thomas, Jérôme Rossert, David A. Power, D.M. Kemeny and Scott Stryker and has published in prestigious journals such as The Journal of Experimental Medicine, International Journal of Molecular Sciences and Kidney International.

In The Last Decade

Marc Van Regenmortel

9 papers receiving 1.5k citations

Hit Papers

Therapeutic antibodies: successes, limitations and hopes ... 2009 2026 2014 2020 2009 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Therapeutic antibodies: successes, limitations and hopes for the future
    2009 1.1k citations Patrick Chames, Marc Van Regenmortel et al. British Journal of Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Van Regenmortel France 8 797 704 523 308 160 9 1.6k
Susan Kirshner United States 15 765 1.0× 616 0.9× 700 1.3× 364 1.2× 188 1.2× 23 1.6k
Syed Rizvi Australia 25 656 0.8× 769 1.1× 517 1.0× 445 1.4× 103 0.6× 56 2.1k
Thomas Emrich Germany 21 886 1.1× 592 0.8× 719 1.4× 401 1.3× 108 0.7× 36 2.1k
Melissa Damschroder United States 23 1.0k 1.3× 882 1.3× 666 1.3× 452 1.5× 88 0.6× 42 2.3k
Yariv Wine Israel 18 741 0.9× 606 0.9× 589 1.1× 169 0.5× 133 0.8× 33 1.6k
Vibha Jawa United States 21 1.1k 1.4× 1.1k 1.6× 988 1.9× 261 0.8× 96 0.6× 46 1.8k
John D. Pound United Kingdom 28 1.3k 1.7× 827 1.2× 1.7k 3.2× 297 1.0× 112 0.7× 52 3.0k
Aaron K. Sato United States 22 1.5k 1.9× 783 1.1× 643 1.2× 697 2.3× 108 0.7× 41 2.5k
Vincent R. Zurawski United States 28 1.0k 1.3× 761 1.1× 677 1.3× 537 1.7× 103 0.6× 44 3.2k
Yusuke Mimura Japan 18 1.8k 2.3× 1.4k 2.0× 970 1.9× 299 1.0× 93 0.6× 58 2.8k

Countries citing papers authored by Marc Van Regenmortel

Since Specialization
Citations

This map shows the geographic impact of Marc Van Regenmortel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Van Regenmortel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Van Regenmortel more than expected).

Fields of papers citing papers by Marc Van Regenmortel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Van Regenmortel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Van Regenmortel. The network helps show where Marc Van Regenmortel may publish in the future.

Co-authorship network of co-authors of Marc Van Regenmortel

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Van Regenmortel. A scholar is included among the top collaborators of Marc Van Regenmortel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Van Regenmortel. Marc Van Regenmortel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Regenmortel, Marc Van. (2016). Structure-Based Reverse Vaccinology Failed in the Case of HIV Because it Disregarded Accepted Immunological Theory. International Journal of Molecular Sciences. 17(9). 1591–1591. 26 indexed citations
2.
Chames, Patrick, Marc Van Regenmortel, Étienne Weiss, & Daniel Baty. (2009). Therapeutic antibodies: successes, limitations and hopes for the future. British Journal of Pharmacology. 157(2). 220–233. 1065 indexed citations breakdown →
3.
Chen, Shu‐wen W., Marc Van Regenmortel, & Jean‐Luc Pellequer. (2009). Structure-Activity Relationships in Peptide-Antibody Complexes: Implications for Epitope Prediction and Development of Synthetic Peptide Vaccines. Current Medicinal Chemistry. 16(8). 953–964. 53 indexed citations
4.
Boven, Katia, Scott Stryker, John Knight, et al.. (2005). The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringes. Kidney International. 67(6). 2346–2353. 149 indexed citations
5.
Maccioni, Mariana, Gabrielle Zeder‐Lutz, Haochu Huang, et al.. (2002). Arthritogenic Monoclonal Antibodies from K/BxN Mice. The Journal of Experimental Medicine. 195(8). 1071–1077. 181 indexed citations
6.
Lopez‐Bergami, Pablo, Patricia Cabeza Meckert, Gabriela Levitus, et al.. (1997). Immunization with recombinantTrypanosoma cruziribosomal P2β protein induces changes in the electrocardiogram of immunized mice. FEMS Immunology & Medical Microbiology. 18(1). 75–85. 29 indexed citations
7.
Frisch, Benoı̂t, Sylviane Muller, Jean Paul Briand, Marc Van Regenmortel, & Francis Schuber. (1991). Parameters affecting the immunogenicity of a liposome‐associated synthetic hexapeptide antigen. European Journal of Immunology. 21(1). 185–193. 31 indexed citations
8.
Yolken, Robert H., et al.. (1984). The use of beta-lactamase in enzyme immunoassays for detection of microbial antigens. Journal of Immunological Methods. 73(1). 109–123. 15 indexed citations
9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan Kirshner Breakdown of academic impact, for papers by Syed Rizvi Breakdown of academic impact, for papers by Thomas Emrich Breakdown of academic impact, for papers by Melissa Damschroder Breakdown of academic impact, for papers by Yariv Wine Breakdown of academic impact, for papers by Vibha Jawa Breakdown of academic impact, for papers by John D. Pound Breakdown of academic impact, for papers by Aaron K. Sato Breakdown of academic impact, for papers by Vincent R. Zurawski Breakdown of academic impact, for papers by Yusuke Mimura
Rankless by CCL
2026